Induction of neuroserpin expression in rat frontal cortex after chronic antidepressant treatment and electroconvulsive treatment. 2006

Satoshi Tanaka, and Misa Yamada, and Sari Kitahara, and Teruhiko Higuchi, and Kazuo Honda, and Kunitoshi Kamijima, and Mitsuhiko Yamada
Department of Psychiatry, Showa University School of Medicine.

Using expressed sequence tag (EST) analysis, we previously identified certain molecular machinery that mediates antidepressant effects. To date, several partial cDNA fragments, termed antidepressant-related genes (ADRGs), have been isolated as ESTs from rat brain. In the present study, we identified two of the ADRGs to be rat neuroserpin. Using real-time quantitative PCR, we demonstrated increased neuroserpin mRNA expression in rat frontal cortex after chronic treatment with several classes of antidepressants, including imipramine, fluoxetine, sertraline, and venlafaxine. Electroconvulsive treatment (ECT), another therapeutic treatment for depression, also increased neuroserpin expression in rat frontal cortex. Neuroserpin is a serine protease inhibitor that is implicated in the regulation of synaptic plasticity, neuronal migration, and axogenesis in the central nervous system. In conclusion, our results support the hypothesis that neuroserpin-mediated plastic changes in frontal cortex may underlie the therapeutic action of antidepressants and ECT.

UI MeSH Term Description Entries
D007099 Imipramine The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group. Imidobenzyle,Imizin,4,4'-Methylenebis(3-hydroxy-2-naphthoic acid)-3-(10,11-dihydro-5H-dibenzo(b,f)azepin-5-yl)-N,N-dimethyl-1-propanamine (1:2),Imipramine Hydrochloride,Imipramine Monohydrochloride,Imipramine Pamoate,Janimine,Melipramine,Norchlorimipramine,Pryleugan,Tofranil
D008297 Male Males
D009479 Neuropeptides Peptides released by NEURONS as intercellular messengers. Many neuropeptides are also hormones released by non-neuronal cells. Neuropeptide
D003511 Cyclohexanols Monohydroxy derivatives of cyclohexanes that contain the general formula R-C6H11O. They have a camphorlike odor and are used in making soaps, insecticides, germicides, dry cleaning, and plasticizers. Cyclohexanol
D004565 Electroconvulsive Therapy Electrically induced CONVULSIONS primarily used in the treatment of severe AFFECTIVE DISORDERS and SCHIZOPHRENIA. Convulsive Therapy, Electric,ECT (Psychotherapy),Electroshock Therapy,Shock Therapy, Electric,Convulsive Therapies, Electric,Electric Convulsive Therapies,Electric Convulsive Therapy,Electric Shock Therapies,Electric Shock Therapy,Electroconvulsive Therapies,Electroshock Therapies,Shock Therapies, Electric,Therapies, Electric Convulsive,Therapies, Electric Shock,Therapies, Electroconvulsive,Therapies, Electroshock,Therapy, Electric Convulsive,Therapy, Electric Shock,Therapy, Electroconvulsive,Therapy, Electroshock
D005473 Fluoxetine The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants. Fluoxetin,Fluoxetine Hydrochloride,Lilly-110140,N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine,Prozac,Sarafem,Lilly 110140,Lilly110140
D005625 Frontal Lobe The part of the cerebral hemisphere anterior to the central sulcus, and anterior and superior to the lateral sulcus. Brodmann Area 8,Brodmann's Area 8,Frontal Cortex,Frontal Eye Fields,Lobus Frontalis,Supplementary Eye Field,Area 8, Brodmann,Area 8, Brodmann's,Brodmanns Area 8,Cortex, Frontal,Eye Field, Frontal,Eye Field, Supplementary,Eye Fields, Frontal,Frontal Cortices,Frontal Eye Field,Frontal Lobes,Lobe, Frontal,Supplementary Eye Fields
D000069470 Venlafaxine Hydrochloride A cyclohexanol and phenylethylamine derivative that functions as a SEROTONIN AND NORADRENALINE REUPTAKE INHIBITOR (SNRI) and is used as an ANTIDEPRESSIVE AGENT. 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)cyclohexanol HCl,Cyclohexanol, 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)-, hydrochloride,Dobupal,Efexor,Effexor,Sila-Venlafaxine,Trevilor,Vandral,Venlafaxine,Wy 45030,Wy-45,030,Wy-45030,Hydrochloride, Venlafaxine,Sila Venlafaxine,Wy 45,030,Wy45,030,Wy45030
D000097522 Neuroserpin An inhibitory serpin that inhibits PLASMINOGEN ACTIVATORS (tPA) in the brain. PI12 Protein,Peptidase Inhibitor 12,SERPINI1 Protein,SERPIN-I1,12, Peptidase Inhibitor,Inhibitor 12, Peptidase,Protein, PI12,Protein, SERPINI1,SERPIN I1
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Satoshi Tanaka, and Misa Yamada, and Sari Kitahara, and Teruhiko Higuchi, and Kazuo Honda, and Kunitoshi Kamijima, and Mitsuhiko Yamada
March 2003, Journal of neural transmission (Vienna, Austria : 1996),
Satoshi Tanaka, and Misa Yamada, and Sari Kitahara, and Teruhiko Higuchi, and Kazuo Honda, and Kunitoshi Kamijima, and Mitsuhiko Yamada
September 2005, The international journal of neuropsychopharmacology,
Satoshi Tanaka, and Misa Yamada, and Sari Kitahara, and Teruhiko Higuchi, and Kazuo Honda, and Kunitoshi Kamijima, and Mitsuhiko Yamada
January 2002, The pharmacogenomics journal,
Satoshi Tanaka, and Misa Yamada, and Sari Kitahara, and Teruhiko Higuchi, and Kazuo Honda, and Kunitoshi Kamijima, and Mitsuhiko Yamada
April 2001, Neuroscience letters,
Satoshi Tanaka, and Misa Yamada, and Sari Kitahara, and Teruhiko Higuchi, and Kazuo Honda, and Kunitoshi Kamijima, and Mitsuhiko Yamada
November 2005, Journal of pharmacological sciences,
Satoshi Tanaka, and Misa Yamada, and Sari Kitahara, and Teruhiko Higuchi, and Kazuo Honda, and Kunitoshi Kamijima, and Mitsuhiko Yamada
October 1993, Journal of neurochemistry,
Satoshi Tanaka, and Misa Yamada, and Sari Kitahara, and Teruhiko Higuchi, and Kazuo Honda, and Kunitoshi Kamijima, and Mitsuhiko Yamada
January 2005, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
Satoshi Tanaka, and Misa Yamada, and Sari Kitahara, and Teruhiko Higuchi, and Kazuo Honda, and Kunitoshi Kamijima, and Mitsuhiko Yamada
September 2008, Synapse (New York, N.Y.),
Satoshi Tanaka, and Misa Yamada, and Sari Kitahara, and Teruhiko Higuchi, and Kazuo Honda, and Kunitoshi Kamijima, and Mitsuhiko Yamada
May 1995, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
Satoshi Tanaka, and Misa Yamada, and Sari Kitahara, and Teruhiko Higuchi, and Kazuo Honda, and Kunitoshi Kamijima, and Mitsuhiko Yamada
July 1998, Progress in neuro-psychopharmacology & biological psychiatry,
Copied contents to your clipboard!